Cite
HARVARD Citation
Laufer, R. et al. (2016). Discovery of 4-(4-aminopyrazolo[1, 5-a][1, 3, 5]triazin-8-yl)benzamides as novel, highly potent and selective, orally bioavailable inhibitors of Tyrosine Threonine Kinase, TTK. Bioorganic & medicinal chemistry letters. 26 (15), pp. 3562-3566. [Online].